Evidence map›Paper›PMID 11165455›Full record

ArticleAmerican journal of preventive medicine2001

Physician-patient discussions of controversial cancer screening tests.

A S Dunn, K V Shridharani, W Lou, J Bernstein, C R Horowitz

Abstract read
In one paragraph

Article in American journal of preventive medicine, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  7. Prostate-Specimen Antigen (PSA) Screening and Shared Decision Making Among Deaf and Hearing Male Patients.Journal of cancer education : the official journal of the American Association for Cancer Education · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Primary Care Physicians' Support of Shared Decision Making for Different Cancer Screening Decisions.Medical decision making : an international journal of the Society for Medical Decision Making · 2017
    Article
  16. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.Journal of cancer education : the official journal of the American Association for Cancer Education · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

A S DunnDepartments of Medicine, Mount Sinai School of Medicine, New York, New York 10029, USA. andrew.dunn@mssm.edu
K V Shridharani
W Lou
J Bernstein
C R Horowitz

Funding

REDUCING UNDERUSE OF EARLY STAGE BREAST CANCER TREATMENTP01HS010859 · AHRQ · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI CHASSIN, MARK R · 2000 to 2004
–
AHRQ HHS P01 HS010859
6 · The paper itself

Abstract

backgroundScreening mammography for younger women and prostate-specific antigen (PSA) measurement have controversial benefits and known potential adverse consequences. While providing informed consent and eliciting patient preference have been advocated for these tests, little is known about how often these discussions take place or about barriers to these discussions.

methodsWe administered a survey to medical house staff and attending physicians practicing primary care. The survey examined physicians' likelihood of discussing screening mammography and PSA testing, and factors influencing the frequency and quality of these discussions.

resultsFor the three scenarios, 16% to 34% of physicians stated that they do not discuss the screening tests. The likelihood of having a discussion was significantly associated with house staff physicians' belief that PSA screening is advantageous; house staff and attending physicians' intention to order a PSA test, and attending physicians' intention to order a mammogram; and a controversial indication for screening. The most commonly identified barriers to discussions were lack of time, the complexity of the topic, and a language barrier.

conclusionsPhysicians report they often do not discuss cancer screening tests with their patients. Our finding that physicians' beliefs and intention to order the tests, and extraneous factors such as time constraints and a language barrier, are associated with discussions indicates that some patients may be inappropriately denied the opportunity to choose whether to screen for breast and prostate cancer.

Indexed as

CommunicationInformed ConsentPhysician-Patient RelationsBreast NeoplasmsFemaleHumansMaleMammographyProstate-Specific AntigenProstatic NeoplasmsProstate-Specific Antigen

Identifiers

PMID11165455
PMCPMC4848038

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.